The meniscal tear outcome (METRO) review: A systematic review summarising the clinical course and outcomes of patients with a meniscal tear

医学 梅德林 物理疗法 心理干预 弯月面 外科 前瞻性队列研究 系统回顾 眼泪 入射(几何) 物理 光学 精神科 政治学 法学
作者
Imran Ahmed,Fatema Dhaif,Chetan Khatri,Nick Parsons,Charles Hutchinson,Sophie Staniszewska,Andrew Price,Andrew Metcalfe
出处
期刊:Knee [Elsevier BV]
卷期号:38: 117-131 被引量:4
标识
DOI:10.1016/j.knee.2022.07.002
摘要

Meniscal tears affect 222 per 100,000 of the population and can be managed non-operatively or operatively with an arthroscopic partial meniscectomy (APM), meniscal repair or meniscal transplantation. The purpose of this review is to summarise the outcomes following treatment with a meniscal tear and explore correlations between outcomes.A systematic review was performed of MEDLINE, EMBASE, AMED and the Cochrane Central Register of Controlled Trials to identify prospective studies describing the outcomes of patients with a meniscal tear. Comparisons were made of outcomes between APM and non-operative groups. Outcomes were graphically presented over time for all treatment interventions. Pearson's correlations were calculated between outcome timepoints.35 studies were included, 28 reported outcomes following APM; four following meniscal repair and three following meniscal transplant. Graphical plots demonstrated a sustained improvement for all treatment interventions. A moderate to very strong correlation was reported between baseline and three-month outcomes. In the medium term, there was small significant difference in outcome between APM and non-operative measures (SMD 0.17; 95 % CI 0.04, 0.29), however, this was not clinically significant.Patients with a meniscal tear demonstrated a sustained initial improvement in function scores, which was true of all treatments examined. APM may have little benefit in older people, however, previous trials did not include patients who meet the current indications for surgery as a result the findings should not be generalised to all patients with a meniscal tear. Further trials are required in patients who meet current operative indications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
蒋灵馨完成签到 ,获得积分10
1秒前
israr完成签到,获得积分10
1秒前
iu发布了新的文献求助10
1秒前
1秒前
hjyylab应助研友_851KE8采纳,获得10
1秒前
羊驼驼完成签到,获得积分10
2秒前
2秒前
科研通AI5应助可青采纳,获得10
2秒前
3秒前
Orange应助yummy采纳,获得10
4秒前
ONION完成签到,获得积分10
4秒前
zhao完成签到 ,获得积分10
4秒前
在水一方应助小Y采纳,获得10
4秒前
NexusExplorer应助科研通管家采纳,获得10
4秒前
5秒前
JamesPei应助科研通管家采纳,获得10
5秒前
科研通AI5应助科研通管家采纳,获得10
5秒前
5秒前
科研通AI5应助科研通管家采纳,获得30
5秒前
Cherish应助JAY23采纳,获得10
5秒前
lxlcx应助企鹅乌云采纳,获得30
5秒前
hh完成签到 ,获得积分20
5秒前
24完成签到,获得积分20
5秒前
思源应助科研通管家采纳,获得10
6秒前
孙燕应助科研通管家采纳,获得10
6秒前
刘洋发布了新的文献求助30
6秒前
领导范儿应助科研通管家采纳,获得10
6秒前
脑洞疼应助11采纳,获得10
6秒前
cxlcxl完成签到,获得积分20
6秒前
丘比特应助科研通管家采纳,获得10
6秒前
一帆风顺发布了新的文献求助10
6秒前
丘比特应助11采纳,获得10
6秒前
英俊的铭应助科研通管家采纳,获得10
6秒前
星辰大海应助遇见采纳,获得10
6秒前
彭于晏应助科研通管家采纳,获得10
6秒前
852应助科研通管家采纳,获得10
7秒前
mjn发布了新的文献求助10
7秒前
情怀应助科研通管家采纳,获得10
7秒前
慕青应助科研通管家采纳,获得10
7秒前
英姑应助科研通管家采纳,获得10
7秒前
高分求助中
Thinking Small and Large 500
Algorithmic Mathematics in Machine Learning 500
Mapping the Stars: Celebrity, Metonymy, and the Networked Politics of Identity 400
Getting Published in SSCI Journals: 200+ Questions and Answers for Absolute Beginners 300
Experimental Design for the Life Sciences 200
Semiconductor Wafer Bonding: Science Technology, and Applications VI 200
Parallel Optimization 200
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3835852
求助须知:如何正确求助?哪些是违规求助? 3378260
关于积分的说明 10503027
捐赠科研通 3097775
什么是DOI,文献DOI怎么找? 1706063
邀请新用户注册赠送积分活动 820776
科研通“疑难数据库(出版商)”最低求助积分说明 772292